Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
March 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | 31 |
April 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 |
May 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on April 3, 2026
Apr. 3, 2026
Das wachsende Interesse an Barttransplantationen in Deutschland führt Patienten nach Istanbul
Indeterminate
EIN Presswire
Apr. 3, 2026
Crece el interés de pacientes españoles por el trasplante capilar en Estambul
Indeterminate
EIN Presswire
Apr. 3, 2026
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Indeterminate
GlobeNewswire
Apr. 3, 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Indeterminate
GlobeNewswire
Apr. 3, 2026
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
Indeterminate
GlobeNewswire
Apr. 3, 2026
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire